Safety and Efficacy of PG101 for Dry Eye Syndrome

NCT02078661 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndrome

Interventions

DRUG: PG101

Sponsor

Rhodes Pharmaceuticals, L.P.

Collaborators

[object Object]